retatrutide vision loss Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation The Thriving Black Market for

Providers also help explain potential out-of-network costs and eligible payment options, including the use of flexible spending accounts (FSAs) or health savings accounts (HSAs)

Aons 2025 Health Survey saw that two-thirds of respondents are waiting for a higher cost threshold or remain uncertain about when to act

lillydirect.lilly.com Anthem

116 (5): e681-6

And thats where a lot of these gut symptoms come from

Overall, these data are encouraging that novel weight-loss medications are effective at reducing body weight and they are also effective at improving many of the cardiometabolic complications of obesity including hypertension, Type 2 diabetes and dyslipidemia, among others